Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
pimicotinib (ABSK021)
i
Other names:
ABSK021, ABSK-021, ABSK 021
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Abbisko, EMD Serono, Sperogenix Therap
Drug class:
CSF-1R inhibitor
Related drugs:
‹
avapritinib (13)
TPX-0022 (8)
pexidartinib (6)
pacritinib (3)
HX301 (2)
vorolanib (1)
OPN-7486 (1)
BMS-986227 (1)
CS 2164 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
axatilimab-csfr (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
avapritinib (13)
TPX-0022 (8)
pexidartinib (6)
pacritinib (3)
HX301 (2)
vorolanib (1)
OPN-7486 (1)
BMS-986227 (1)
CS 2164 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
axatilimab-csfr (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CSF1R overexpression
Osteosarcoma
CSF1R overexpression
Osteosarcoma
ABSK021
Sensitive: D – Preclinical
ABSK021
Sensitive
:
D
ABSK021
Sensitive: D – Preclinical
ABSK021
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login